Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B.

Taiyu He, Min Chen, Maoying Liu, Li Zhang, Huidan Sun, Lu Zhang, Aoyi Li, Weiqun Zeng, Ning Ling, Xiaofeng Shi, Hua He, Mingli Peng, Dachuan Cai, Peng Hu, Dazhi Zhang